Cel Sci Corp SEC filings CVM
Cel Sci Corp has 1,007 filings in SEC EDGAR's recent list, going back to Jun 12, 2012. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 17, 2026 (shareholder vote results). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jul 2, 2026 | Sep 30, 2025 |
| 10-K | Annual report | Dec 29, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Jan 13, 2025 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Mar 7, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Dec 21, 2023 | Sep 30, 2023 |
| ARS | Annual report to shareholders | Apr 10, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Dec 27, 2022 | Sep 30, 2022 |
| ARS | Annual report to shareholders | Apr 29, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Dec 21, 2021 | Sep 30, 2021 |
| ARS | Annual report to shareholders | May 18, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Dec 29, 2020 | Sep 30, 2020 |
| ARS | Annual report to shareholders | Mar 4, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Dec 23, 2019 | Sep 30, 2019 |
| 10-K | Annual report | Dec 16, 2019 | Sep 30, 2019 |
| ARS | Annual report to shareholders | Mar 26, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Dec 19, 2018 | Sep 30, 2018 |
| ARS | Annual report to shareholders | Aug 8, 2018 | Sep 30, 2017 |
| 10-K | Annual report | Dec 29, 2017 | Sep 30, 2017 |
| 10-K/A | Amended annual report | Dec 11, 2017 | Sep 30, 2016 |
| ARS | Annual report to shareholders | Apr 27, 2017 | Sep 30, 2016 |
| 10-K/A | Amended annual report | Dec 15, 2016 | Sep 30, 2016 |
| 10-K | Annual report | Dec 14, 2016 | Sep 30, 2016 |
| ARS | Annual report to shareholders | Jun 9, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Dec 11, 2015 | Sep 30, 2015 |
| 10-K/A | Amended annual report | Jul 17, 2015 | Sep 30, 2014 |
| ARS | Annual report to shareholders | May 8, 2015 | Dec 31, 2014 |
| 10-K/A | Amended annual report | Apr 17, 2015 | Sep 30, 2014 |
| 10-K | Annual report | Dec 23, 2014 | Sep 30, 2014 |
| ARS | Annual report to shareholders | Jun 9, 2014 | Sep 30, 2013 |
| 10-K | Annual report | Dec 27, 2013 | Sep 30, 2013 |
| 10-K | Annual report | Dec 14, 2012 | Sep 30, 2012 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CVM (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- CO
- Headquarters
- Vienna, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 725363
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.